Synthesis of [3H](4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: A potent radioligand for corticotropin-releasing hormone type 1 receptor

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 43, Issue 9, 2000, Pages 899-908

  Hsin, Ling Wei ^a   Webster, Elizabeth L ^b   Chrousos, George P ^c   Gold, Philip W ^b   Eckelman, William C ^d   Contoreggi, Carlo ^e   Rice, Kenner C ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Antalarmin; Corticotropin releasing hormone; Positron emission tomography; Radioligand; Tritium

Indexed keywords

FLUORINE COMPOUNDS; POSITRONS; TRITIUM;

ANTALARMIN; CATALYTIC REDUCTION; CORTICOTROPIN-RELEASING HORMONE; NONPEPTIDE; RADIOLABELED ANALOGS; RADIOLIGANDS; TOTAL YIELD; TRIMETHYL; TRITIATION; TRITIUM GAS;

POSITRON EMISSION TOMOGRAPHY;

ANTALARMIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; FLUORIDE; PALLADIUM; RADIOLIGAND; TRITIUM;

ARTICLE; CATALYST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRECURSOR; PURIFICATION; RADIOCHEMISTRY; SYNTHESIS;

EID: 0033910490     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1344(200008)43:9<899::AID-JLCR375>3.0.CO;2-N     Document Type: Article

References (14)

1. Chrousos G.P. Engl. J. Med. 332: 1351 (1995).
2. Owens M.J. and Nemeroff C.B. Pharmacol. Rev. 43: 425 (1991).
3. Vale W., Spiess J., Rivier C., and Rivier J. Science 213: 1394 (1981).
4. McCarthy J.R., Heinrichs S.C., and Grigoriadis D.E. Annual Reports in Medicinal Chemistry 34: 11 (1999).
5. Bremner J.D., Licinio J., Darnell A., Krystall J.H., Owens M.J., Southwick S.M., Nemeroff C.B., and Charney D.S. Am. J. Psychiatry 154: 624 (1997).
6. Nemreoff C.B., Widerlov E., Bissette G., Wallens H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., and Vale W. Science 226: 1342 (1984).
7. Zhou Y., Spangler R., LaForge K.S., Maggos C.E., Ho A., and Kreek M.J. J. Pharmacol. Exp. Ther. 279: 351 (1996).
8. Holsboer F. Journal of Psychiatric Research 33: 181 (1999).
9. Hsin L.-W., Webster E.L., Chrousos G.P., Gold, P.W., Eckelman W.C., Contoreggi C., and Rice K.C. Bioorg. Med. Chem. Lett. (in press).
10. McCarthy J.R., Heinrichs S.C., and Grigoriadis D.E. Current Pharmaceutical Design 5: 289 (1999).
11. Chen Y.L., Mansbach R.S., Winter S.M., Brooks E., Collins J., Corman M.L., Dunaiskis A.R., Faraci W.S., Gallaschun R.J., Schmidt A., and Schulz D.W. J. Med. Chem. 40: 1749 (1997).
12. Chorvat R.J., Bakthavatchalam R., Beck J.P., Gilligan P.J., Wilde R.G., Cocuzza A.J., Hobbs F.W., Cheeseman R.S., Curry M., Rescinito J.P., Krenitsky P., Chidester D., Yarem J.A., Klaczkiewicz J.D., Hodge C.N., Aldrich P.E., Wasserman Z.R., Fernandez C.H., Zaczek R., Fitzgerald L.W., Huang S.M., Shen H.L., Wong Y.N., Chien B.M., Quon C.Y., and Arvanitis A. J. Med. Chem. 42: 833 (1999).
13. Chen Y.L. International Publication Number WO 9413676-A1.
14. Shimizu M., Nakahara Y., and Yoshioka H. Tetrahedron Lett. 26: 4207 (1985).